Medicare Part D reimburses for “prescription only” drugs and does not reimburse for over-the counter-drugs, the Justice Department said in a Sept. 14 news release. Akorn admitted it delayed seeking the required conversions of three of its generic drugs from prescription only to over-the-counter status and continued to sell newly manufactured units of those drugs under the obsolete “prescription only” labeling.
Allegations were originally brought through a whistleblower complaint, according to the release. The whistleblower will receive $946,000 of the settlement money.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
